Alkem launches breast cancer treatment drug palbociclib (Palbo) in India
The drug comes in capsule form in multiple dose strengths with varied pricing ranges, including 125 mg at Rs 6,125/- for 21…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
palbociclib
Dr Reddy’s launches in-house palbociclib to widen access to breast cancer drug
Dr Reddy's is among select companies to have conducted bioequivalence study, and has already received tentative approval from the…
BDR Pharma launches generic Palbociclib for breast cancer treatment
The drug will be made available in three strengths i.e. – 125 mg, 100 mg and 75 mg capsules priced at Rs 3,150 for 75 mg; Rs 3,600…
Sun Pharma launches Palbociclib, therapy for advanced breast cancer
Sun Pharma’s brand, Palentom, is the branded generic version of the innovator product
Pfizer files patent infringement petition in US court against Aurobindo, Dr Reddy’s
Alleges that these Indian pharma companies were planning separately to come out with generic versions of its cancer drug Ibrance…
IBRANCE (palbociclib) fails trial for early breast cancer treatment
No unexpected safety signals were observed and it did not meet improved invasive disease-free survival in women with HR+, HER2-…